Seattle Genetics | SGEN - Attività Correnti



Attività Correnti Cambiamento Data
AbbVie USD 33.53B 4.47B 2026-03
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Astellas Pharma JPY 1.42T 19.35B 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Celldex Therapeutics USD 459.22M 75.44M 2026-03
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Eisai JPY 761.64B 79.24B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
MacroGenics USD 182.52M 37.42M 2026-03
Merck USD 35.02B 8.5B 2026-03
Moderna USD 5.77B 774M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Sanofi EUR 30.16B 789M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Takeda JPY 3.09T 25.94B 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xencor USD 482.85M 116.97M 2026-03